Your browser doesn't support javascript.
loading
Recent progress in HIV-1 inhibitors targeting the entrance channel of HIV-1 non-nucleoside reverse transcriptase inhibitor binding pocket.
Gu, Shuang-Xi; Xiao, Ting; Zhu, Yuan-Yuan; Liu, Gen-Yan; Chen, Fen-Er.
Affiliation
  • Gu SX; Key Laboratory for Green Chemical Process of Ministry of Education, School of Chemical Engineering and Pharmacy, Wuhan Institute of Technology, Wuhan 430205, PR China. Electronic address: shuangxigu@163.com.
  • Xiao T; Key Laboratory for Green Chemical Process of Ministry of Education, School of Chemical Engineering and Pharmacy, Wuhan Institute of Technology, Wuhan 430205, PR China.
  • Zhu YY; School of Chemistry and Environmental Engineering, Wuhan Institute of Technology, Wuhan 430205, PR China.
  • Liu GY; Key Laboratory for Green Chemical Process of Ministry of Education, School of Chemical Engineering and Pharmacy, Wuhan Institute of Technology, Wuhan 430205, PR China.
  • Chen FE; Key Laboratory for Green Chemical Process of Ministry of Education, School of Chemical Engineering and Pharmacy, Wuhan Institute of Technology, Wuhan 430205, PR China; Department of Chemistry, Fudan University, Shanghai 200433, PR China. Electronic address: rfchen@fudan.edu.cn.
Eur J Med Chem ; 174: 277-291, 2019 Jul 15.
Article in En | MEDLINE | ID: mdl-31051402
Since the entrance channel was proposed as a new binding site in non-nucleoside reverse transcriptase inhibitor binding pocket (NNIBP) of HIV-1 reverse transcriptase (RT) in 2012, a huge number of HIV-1 inhibitors acting on this target have sprung up, aiming to discover promising inhibitors with excellent antiviral activities, physicochemical properties, and so on. From 2012 to 2018, many noteworthy compounds have been continuously discovered. In this review, the recent progress in HIV-1 inhibitors targeting the entrance channel of HIV-1 NNIBP was summarized and reviewed, which would provide useful clues and inspiration for further design of HIV-1 inhibitors.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: HIV-1 / Reverse Transcriptase Inhibitors / Anti-HIV Agents / HIV Reverse Transcriptase / Heterocyclic Compounds Limits: Animals / Humans Language: En Journal: Eur J Med Chem Year: 2019 Document type: Article Country of publication:

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: HIV-1 / Reverse Transcriptase Inhibitors / Anti-HIV Agents / HIV Reverse Transcriptase / Heterocyclic Compounds Limits: Animals / Humans Language: En Journal: Eur J Med Chem Year: 2019 Document type: Article Country of publication: